Accordingly, I rate Organogenesis as a "Hold". Analyst’s Disclosure: I/we have a beneficial long position in the shares of ORGO either through stock ownership, options, or other derivatives.

1 Day ORGO -4.57% DJIA 1.65% Russell 2K 2.53% Health Care/Life Sciences 0.14% ...